Published in J Clin Endocrinol Metab on August 01, 1994
A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet (2002) 1.87
Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2001) 1.59
A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet (2000) 1.31
Admixture mapping of quantitative trait loci for BMI in African Americans: evidence for loci on chromosomes 3q, 5q, and 15q. Obesity (Silver Spring) (2009) 1.12
Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study. PLoS One (2014) 1.02
Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring) (2008) 1.01
A role of apolipoprotein D in triglyceride metabolism. J Lipid Res (2010) 0.93
Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY) (2009) 0.92
Genetic variation in apolipoprotein D and Alzheimer's disease. J Neurol (2004) 0.87
Characterization of the hypothalamic transcriptome in response to food deprivation reveals global changes in long noncoding RNA, and cell cycle response genes. Genes Nutr (2015) 0.77
Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling. Am J Physiol Heart Circ Physiol (2011) 0.75
Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes. Sci Rep (2017) 0.75
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia (1985) 3.65
Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc (2001) 3.36
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26
DNA polymorphic haplotypes on the short arm of chromosome 11 and the inheritance of type I diabetes mellitus. J Med Genet (1986) 2.86
Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM (2002) 2.50
A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia (1994) 2.25
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet (1979) 1.95
Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. J Med Genet (1997) 1.88
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia (2004) 1.54
The perception of angina in diabetes: relation to somatic pain threshold and autonomic function. Am Heart J (1991) 1.51
Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess (2005) 1.51
The genetic predisposition to fibrocalculous pancreatic diabetes. Diabetologia (1989) 1.46
An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q. Arthritis Rheum (2000) 1.41
Interpretation and management of PACT (prescribing analysis and cost) data on formularies. BMJ (1990) 1.38
Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann Hum Genet (2003) 1.33
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord (2000) 1.30
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26
Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet (2005) 1.24
Familial aggregation of type 2 (non-insulin-dependent) diabetes mellitus in south India; absence of excess maternal transmission. Diabet Med (1996) 1.14
Linkage of familial Hibernian fever to chromosome 12p13. Am J Hum Genet (1998) 1.14
Susceptibility to coeliac disease involves genes in HLA-DP region. Lancet (1987) 1.12
New HLA DNA polymorphisms associated with autoimmune diseases. Nature (1986) 1.11
Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia (2005) 1.11
Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol (1993) 1.11
Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) (1980) 1.09
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun (2004) 1.09
Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ (1993) 1.08
Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity. Clin Endocrinol (Oxf) (1985) 1.06
TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun (2004) 1.06
Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. J Med Genet (2007) 1.03
Diabetic hypertriglyceridaemia and related 5' flanking polymorphism of the human insulin gene. Br Med J (Clin Res Ed) (1984) 1.02
A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J Peripher Nerv Syst (2001) 1.02
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. Atherosclerosis (2003) 1.01
Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples. Diabet Med (2005) 1.01
An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol (1992) 1.01
Evidence for existence of two types of massive obesity. Br Med J (1980) 0.99
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia (1997) 0.99
An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia (1999) 0.97
Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf) (1997) 0.96
Familial aggregation in tropical fibrocalculous pancreatic diabetes. Pancreas (1989) 0.96
Epistasis between type 2 diabetes susceptibility Loci on chromosomes 1q21-25 and 10q23-26 in northern Europeans. Ann Hum Genet (2006) 0.95
A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitus. Immunogenetics (1986) 0.95
An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia (2006) 0.95
Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol (1990) 0.95
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia (2008) 0.94
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance. Eur J Hum Genet (2001) 0.93
Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia. J Am Coll Cardiol (1990) 0.93
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia (2005) 0.93
Diabetes. Exploding type II. Lancet (1999) 0.90
Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br Med J (1980) 0.90
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. Diabet Med (2002) 0.90
No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. J Clin Endocrinol Metab (2000) 0.90
GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes. Diabet Med (2006) 0.89
HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. Kidney Int (1996) 0.89
Polymorphisms in the 5'-flanking region of the insulin gene and non-insulin-dependent diabetes. Clin Sci (Lond) (1984) 0.88
Aging, autonomic function, and the perception of angina. Br Heart J (1991) 0.88
Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer. Lancet (2002) 0.88
Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes. J R Soc Med (1986) 0.87
Insulin and apolipoprotein A-1/C-III gene polymorphisms relating to hypertriglyceridaemia and diabetes mellitus. Diabetologia (1984) 0.87
An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism. Hum Immunol (1996) 0.86
Family studies of non-insulin-dependent diabetes mellitus in South Indians. Diabetologia (1994) 0.86
Analysis of the contribution to type 2 diabetes susceptibility of sequence variation in the gene encoding stearoyl-CoA desaturase, a key regulator of lipid and carbohydrate metabolism. Diabetologia (2004) 0.86
HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. J Clin Invest (1987) 0.86
The effect of weight loss on sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) (1981) 0.86
Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India. Diabet Med (1994) 0.85
Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. Diabet Med (1998) 0.85
Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin Endocrinol (Oxf) (1996) 0.85
Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5' flanking region of the human insulin gene. Eur J Clin Invest (1992) 0.85
Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia (2000) 0.85
Reduced beta cell function in offspring of mothers with young-onset type 2 diabetes. Diabetologia (2006) 0.85
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. Diabet Med (2004) 0.84
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes. Diabet Med (2011) 0.84
Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK population. Diabetologia (2006) 0.84
Familial aggregation of central obesity in Southern Indians. Int J Obes Relat Metab Disord (2000) 0.84
Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care (2001) 0.84
Parental influence on the spectrum of type 2 diabetes in the offspring among Indians. J Assoc Physicians India (2007) 0.83
The calcitonin-CGRP gene in the infantile hypercalcaemia/Williams-Beuren syndrome. J Med Genet (1989) 0.83
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis (2007) 0.83
Synthesis of putative metabolites and investigation of the metabolic fate of gliclazide, [1-(3-azabicyclo(3,3,0)oct-3-yl)-3-(4-methylphenylsulfonyl) urea], in diabetic patients. Drug Metab Dispos (1996) 0.83
trkA and trkC expression is increased in human diabetic skin. Neurosci Lett (1997) 0.82
The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet (1996) 0.82
Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Res Rev (2001) 0.82
HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int (1990) 0.82
Options for the management of obesity. Pharmacoeconomics (1994) 0.82
HLA-DP and coeliac disease: family and population studies. Gut (1990) 0.81
Analysis of islet regenerating (reg) gene polymorphisms in fibrocalculous pancreatic diabetes. Pancreas (1997) 0.81
Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol (2001) 0.81
Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol (1996) 0.81
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia (2007) 0.81
In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group. Diabetologia (1995) 0.81
HLA-DP region gene polymorphism in primary IgA nephropathy: no association. Nephrol Dial Transplant (1992) 0.80
Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabet Med (1999) 0.80